PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung cancer |
| Phenotype | C0686619|lymph node metastases |
| Sentences | 8 |
| PubMedID- 20631638 | Introduction: stage iiia non-small cell lung cancer (nsclc) with ipsilateral mediastinal lymph node metastases (n2) is a heterogeneous disease with differing prognoses. |
| PubMedID- 20466499 | Purpose: to evaluate the accuracy of multi-slice computed tomography (msct) in diagnosing mediastinal lymph node metastases in patients with non-small cell lung cancer (nsclc) using a multi-criteria approach. |
| PubMedID- 26377170 | Therefore, in our opinion, the most reasonable explanation for the findings in our case is a primary lung cancer with lymph node metastases. |
| PubMedID- 23788938 | There is only one study in the literature that has investigated the relation between ttf-1 positivity and the occurrence of lymph node metastases in patients with lung cancer, with a limited number of patients [27]. |
| PubMedID- 26557903 | In the present study, we evaluated the frequencies of mediastinal and hilar lymph node metastases in patients with primary lung cancer of the right lower lobe according to tumor location. |
| PubMedID- 23151327 | Conclusion: in more than 50% of lung cancer patients with suspected mediastinal lymph node metastases, cervical mediastinoscopy can be avoided when ebus-tbna is used. |
| PubMedID- 22182444 | Background: this study compares the diagnostic abilities of integrated (11)c-choline pet/ct imaging and contrast-enhanced helical ct imaging in pulmonary lesions and locoregional lymph node metastases in patients with lung cancer. |
| PubMedID- 20811949 | Materials and methods: a total of 56 primary lung cancers with corresponding lymph node metastases were identified to investigate somatic mutations and altered expressions of p53 and egfr for clonality assessment. |
Page: 1